Latest Form 4 insider transactions

Matthew J Lustig, a Director of Ventas, Inc., reported multiple transactions in common stock on October 15, 2026.

Michael J Embler, a Director of Ventas, Inc., received 81 shares of common stock on October 15, 2026.

Melody C Barnes, a Director of Ventas, Inc., received 81 shares of common stock on October 15, 2026.

Robert W Martin, CHIEF EXEC. AND PRES. and a Director of Thor Industries Inc, reported multiple transactions in common stock on October 13, 2026.

Colleen A Zuhl, SR. VP AND CHIEF FIN. OFFICER of Thor Industries Inc, reported multiple transactions in common stock on October 13, 2026.

Charles G Pardee, a Director of HCM II Acquisition Corp., purchased 7,500 shares of common stock on October 14, 2026 for $2.95 per share.

Trevor Q. Gasper, SVP, GENERAL COUNSEL AND SEC. of Thor Industries Inc, reported multiple transactions in common stock on October 13, 2026.

Michele Mcdermott, Chief Human Resources Officer of Thor Industries Inc, reported multiple transactions in common stock on October 13, 2026.

Ryan Aaron Biren, Chief Information Officer of Thor Industries Inc, received 6,898 shares of common stock on October 13, 2026.

Jeffrey D Lorenger, a Director of Thor Industries Inc, received 2,912 shares of common stock on October 13, 2026.

William J. Kelley Jr, a Director of Thor Industries Inc, received 2,912 shares of common stock on October 13, 2026.

Laurel Hurd, a Director of Thor Industries Inc, received 2,912 shares of common stock on October 13, 2026.

Amelia Huntington, a Director of Thor Industries Inc, received 2,912 shares of common stock on October 13, 2026.

James R. Kasinger, General Counsel and Secretary of CRISPR Therapeutics AG, sold 1,040 shares of common stock on October 13, 2026 for $49.26 per share.

Samarth Kulkarni, Chief Executive Officer and a Director of CRISPR Therapeutics AG, sold 4,098 shares of common stock on October 13, 2026 for $49.26 per share.

Christina Hennington, a Director of Thor Industries Inc, received 2,912 shares of common stock on October 13, 2026.

Jeffrey C. Tweedy, a Director of Safe & Green Development Corp, received 8,318 shares of common stock on October 13, 2026.

Christopher Melton, a Director of Safe & Green Development Corp, received 8,254 shares of common stock on October 13, 2026.

J. Scott Magrane, a Director of Safe & Green Development Corp, received 8,294 shares of common stock on October 13, 2026.

Andrew E Graves, a Director of Thor Industries Inc, received 2,912 shares of common stock on October 13, 2026.

Bjarne Erik Siwert Borg, a Director of Safe & Green Development Corp, received 8,500 shares of common stock on October 13, 2026.

Peter G. Demaria, a Director of Safe & Green Development Corp, received 8,294 shares of common stock on October 13, 2026.

W. Todd Woelfer, SVP, CHIEF OPERATING OFFICER of Thor Industries Inc, reported multiple transactions in common stock on October 13, 2026.

Thomas W Florsheim Jr, a Director of Strattec Security Corp, received 1,434 shares of common stock on October 13, 2026.

Patricia W Warfield, a Director of Strattec Security Corp, received 1,434 shares of common stock on October 13, 2026.

R Bruce Mcdonald, a Director of Strattec Security Corp, received 1,434 shares of common stock on October 13, 2026.

Bruce M Lisman, a Director of Strattec Security Corp, received 1,434 shares of common stock on October 13, 2026.

Peter Busch Orthwein, a Director of Thor Industries Inc, received 2,912 shares of common stock on October 13, 2026.

Christopher J Klein, a Director of Thor Industries Inc, received 2,912 shares of common stock on October 13, 2026.

Sumedh S Thakar, CEO & PRESIDENT and a Director of Qualys, Inc., sold 3,200 shares of common stock on October 14, 2026.